Search research articles
Contact Us
Filters
Showing results (71-80 of 166) with videos related to
Page
of 17
Sort By:
Brain Research. Brain Research Protocols
|
May 10, 2005
A brightness-area-product-based protocol for the quantitative assessment of antigen abundance in fluorescent immunohistochemistry
Paul D Smith, Karen J McLean, Michael A Murphy, et al.
Contemporary Clinical Trials Communications
|
February 2, 2019
Design and rationale of a mixed methods randomized control trial: ADdressing Health literacy, bEliefs, adheRence and self-Efficacy (ADHERE) program to improve diabetes outcomes
Olayinka O Shiyanbola, Denise L Walbrandt Pigarelli, Elizabeth J Unni, et al.
Cancer Research
|
August 5, 2008
BRAF V600E disrupts AZD6244-induced abrogation of negative feedback pathways between extracellular signal-regulated kinase and Raf proteins
Bret B Friday, Chunrong Yu, Grace K Dy, et al.
BMJ Health & Care Informatics
|
October 21, 2019
Using normalisation process theory to understand workflow implications of decision support implementation across diverse primary care settings
Rebecca G Mishuris, Joseph Palmisano, Lauren McCullagh, et al.
Annals of Plastic Surgery
|
March 23, 2017
Complications and Recurrence in Implant-Sparing Oncologic Breast Surgery
Joshua B Elston, Sangeetha Prabhakaran, Amina Lleshi, et al.
Cancer Research Communications
|
March 27, 2023
Pharmaceutical Reactivation of Attenuated Apoptotic Pathways Leads to Elimination of Osimertinib Drug-Tolerant Cells
Matthew J Martin, Nicolas Floc'h, Matthias Pfeifer, et al.
Patient Preference and Adherence
|
March 18, 2022
Feasibility of a Randomized Controlled Mixed Methods Trial to Address Health Literacy, Beliefs, Medication Adherence, and Self-Efficacy (ADHERE) in a Clinical Pharmacist-Led Clinic
Olayinka O Shiyanbola, Martha A Maurer, Natasha Virrueta, et al.
Southern Medical Journal
|
October 4, 2017
Early Postoperative Complications after Oncoplastic Reduction
Anne E Mattingly, Zhenjun Ma, Paul D Smith, et al.
Molecular Cancer Therapeutics
|
August 19, 2007
AZD6244 (ARRY-142886), a potent inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1/2 kinases: mechanism of action in vivo, pharmacokinetic/pharmacodynamic relationship, and potential for combination in preclinical models
Barry R Davies, Armelle Logie, Jennifer S McKay, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association
|
October 4, 2013
Health literacy and urbanicity among cancer patients
Julie Halverson, Ana Martinez-Donate, Amy Trentham-Dietz, et al.
Page
of 17
Search research articles
Search
Showing results (71-80 of 166) with videos related to
Sort By:
Page
of 17
Brain Research. Brain Research Protocols
|
May 10, 2005
A brightness-area-product-based protocol for the quantitative assessment of antigen abundance in fluorescent immunohistochemistry
Paul D Smith, Karen J McLean, Michael A Murphy, et al.
Contemporary Clinical Trials Communications
|
February 2, 2019
Design and rationale of a mixed methods randomized control trial: ADdressing Health literacy, bEliefs, adheRence and self-Efficacy (ADHERE) program to improve diabetes outcomes
Olayinka O Shiyanbola, Denise L Walbrandt Pigarelli, Elizabeth J Unni, et al.
Cancer Research
|
August 5, 2008
BRAF V600E disrupts AZD6244-induced abrogation of negative feedback pathways between extracellular signal-regulated kinase and Raf proteins
Bret B Friday, Chunrong Yu, Grace K Dy, et al.
BMJ Health & Care Informatics
|
October 21, 2019
Using normalisation process theory to understand workflow implications of decision support implementation across diverse primary care settings
Rebecca G Mishuris, Joseph Palmisano, Lauren McCullagh, et al.
Annals of Plastic Surgery
|
March 23, 2017
Complications and Recurrence in Implant-Sparing Oncologic Breast Surgery
Joshua B Elston, Sangeetha Prabhakaran, Amina Lleshi, et al.
Cancer Research Communications
|
March 27, 2023
Pharmaceutical Reactivation of Attenuated Apoptotic Pathways Leads to Elimination of Osimertinib Drug-Tolerant Cells
Matthew J Martin, Nicolas Floc'h, Matthias Pfeifer, et al.
Patient Preference and Adherence
|
March 18, 2022
Feasibility of a Randomized Controlled Mixed Methods Trial to Address Health Literacy, Beliefs, Medication Adherence, and Self-Efficacy (ADHERE) in a Clinical Pharmacist-Led Clinic
Olayinka O Shiyanbola, Martha A Maurer, Natasha Virrueta, et al.
Southern Medical Journal
|
October 4, 2017
Early Postoperative Complications after Oncoplastic Reduction
Anne E Mattingly, Zhenjun Ma, Paul D Smith, et al.
Molecular Cancer Therapeutics
|
August 19, 2007
AZD6244 (ARRY-142886), a potent inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1/2 kinases: mechanism of action in vivo, pharmacokinetic/pharmacodynamic relationship, and potential for combination in preclinical models
Barry R Davies, Armelle Logie, Jennifer S McKay, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association
|
October 4, 2013
Health literacy and urbanicity among cancer patients
Julie Halverson, Ana Martinez-Donate, Amy Trentham-Dietz, et al.
Page
of 17